Business Context and Reporting Period
Company: Standex International Corp (SXI)
Filing Type: Form 8-K (Current Report)
Date of Report: October 28, 2024
Reporting Period: Events occurring on October 28, 2024
Standex International Corporation announced the completion of two major acquisitions and the execution of a new term loan facility to fund these transactions.
Key Financial Metrics and Transaction Details
Acquisition Transactions
- Amran, LLC Acquisition:
- Total Consideration: $180,600,000
- Cash Component: $153,510,000 (for 85% interest)
- Stock Component: 152,299 shares of Standex common stock valued at $27,090,000 (for 15% interest)
- Valuation Basis: Stock price based on 30-day volume weighted average ($177.87)
- Narayan Powertech Private Limited Acquisition:
- Initial Stake Acquired: 90.1% via wholly-owned subsidiary Mold-Tech Singapore PTE LTD
- Cash Component: $253,973,880
- Remaining Stake (9.90%): Subject to a future "Share Swap" contingent on Reserve Bank of India (RBI) approval. Value estimated at $27,906,120 to be paid in Standex common stock.
Debt and Liquidity
- New Term Loan: $250,000,000 secured from Citizens Bank, N.A. and other lenders.
- Loan Maturity: October 27, 2025.
- Interest Rate: Variable (Alternate Base Rate or Term SOFR plus applicable margins).
- Use of Proceeds: Funding a portion of the Amran and Narayan transactions.
- Existing Credit Facility: The Revolving Credit Agreement was amended to permit these transactions but otherwise remains unchanged.
Material Changes and Unusual Items
The filing reports significant balance sheet changes due to the simultaneous closing of two acquisitions totaling approximately $434.6 million in initial consideration (cash plus stock value). The company has increased its debt load by $250 million to finance these deals. Additionally, the company issued unregistered equity securities (152,299 shares) to Bolt Founders, Inc. as partial consideration for the Amran acquisition.
Guidance, Outlook, and Risks
- Regulatory Contingency: The acquisition of the remaining 9.90% of Narayan is contingent upon RBI approval. If approval is not received by October 28, 2025, the remaining stake will be subject to put and call options based on fair market value or a formula using adjusted EBITDA.
- Financial Statement Filing: Pro forma financial information and financial statements for the acquired businesses are not included in this filing. They are expected to be filed within 71 days of this report.
- Price Adjustments: Both purchase agreements include post-closing cash adjustments based on working capital estimates and escrow provisions for indemnification claims.
- Lock-up Periods: Securities issued to sellers in both transactions are subject to sale restrictions for the first three years post-closing.
Investor Verification Checklist
- Verify the pro forma financial impact of the $434.6 million in acquisitions once filed within 71 days.
- Monitor the status of the Reserve Bank of India (RBI) approval required for the final 9.90% stake in Narayan.
- Review the terms of the $250 million term loan maturing in October 2025 to assess near-term refinancing or repayment obligations.
- Check for any post-closing working capital adjustments that may alter the final purchase price for Amran and Narayan.
- Confirm the dilution impact of the 152,299 shares issued for Amran and the potential future issuance for Narayan.